{
    "clinical_study": {
        "@rank": "23314", 
        "acronym": "NAV4-04", 
        "arm_group": {
            "arm_group_label": "[18F]NAV4694", 
            "arm_group_type": "Experimental", 
            "description": "Intravenous [18F]NAV4694 (8.1 mCi) administered once every 18 months"
        }, 
        "brief_summary": {
            "textblock": "To investigate whether [18F]NAV4694 positron emission tomography (PET) scan findings have\n      the ability to distinguish subjects with mild cognitive impairment (MCI) who progress to\n      Alzheimer's disease (AD) from those who do not."
        }, 
        "brief_title": "Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI)", 
        "condition": "Mild Cognitive Impairment", 
        "condition_browse": {
            "mesh_term": [
                "Alzheimer Disease", 
                "Cognition Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject has signed informed consent to participate in the study and continues to give\n             willing consent for participation\n\n          -  Age \u2265 55 years with a diagnosis of MCI\n\n          -  Educational level of at least 6 years\n\n          -  Female subjects will not be of child-bearing potential (> 1 year post-menopausal or\n             surgically sterile)\n\n          -  Availability of a \"study partner\" who can assist in completing rating scales for the\n             duration of the study\n\n          -  Cognitive complaints reported by the subject and confirmed by the \"study partner\"\n\n          -  Clinical Dementia Rating (CDR) global score = 0.5\n\n          -  Mini-mental state examination (MMSE) score of 24-30\n\n          -  Diagnostic and Statistical Manual of Mental Disorders, Version 4, Text Revised\n             (DSM-IV-TR) criteria of dementia not fulfilled\n\n        Exclusion Criteria:\n\n          -  Has been previously enrolled in this study and received the investigational product\n\n          -  Has participated in a clinical study involving an investigational pharmaceutical\n             product within 30 days prior to screening\n\n          -  Has received anti-amyloid immunotherapy\n\n          -  Has exceeded yearly radioactive dose of 30 mSv\n\n          -  Has a known allergy to the study drug or any of its constituents\n\n          -  Has a history of alcohol abuse or alcohol dependency in the 3 years prior to study\n             entry, or is an alcoholic or drug addict, as determined by the investigator\n\n          -  Has ongoing clinically significant (as judged by the investigator), metabolic or any\n             other disease that could currently cause impaired memory (e.g., untreated thyroid\n             disease, vitamin or other nutritional deficiencies, chronic kidney, or liver disease)\n\n          -  Regular use of psychoactive medications that could affect cognition (e.g.,\n             benzodiazepines, sedatives, antipsychotics)\n\n          -  Has received any contrast material (X-ray, MRI) or radiopharmaceutical within 48\n             hours prior to, or a therapeutic radiopharmaceutical (e.g., 131I) within 10 days\n             prior to, or any radiopharmaceutical administration within 10 radioactive half-lives\n             prior to the administration of the investigational product or for whom administration\n             of such substances is planned within 7 days after investigational product\n             administration\n\n          -  History of major recurrent depressive disorder (per DSM-IV-TR) within the last 5\n             years prior to screening\n\n          -  Has a brain tumor or other intracranial lesion, a disturbance of cerebral spinal\n             fluid circulation (e.g., normal pressure hydrocephalus), and/or a significant history\n             of head trauma or brain surgery\n\n          -  Has signs of major cerebrovascular disease, as verified by medical history and/or\n             brain MRI\n\n          -  Is scheduled for surgery and/or another invasive procedure within the 7 days\n             following investigational product administration\n\n          -  Has any contraindication to MRI examination, e.g., metal implants, phobia, or cannot\n             undergo an MRI for other reasons such as the inability to lie flat\n\n          -  Memory impairment that can be attributed to a disease or condition other than an\n             early phase neurodegenerative syndrome\n\n          -  Has a Parkinsonian movement disorder"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "55 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01812213", 
            "org_study_id": "NAV4-04"
        }, 
        "intervention": {
            "arm_group_label": "[18F]NAV4694", 
            "intervention_name": "[18F]NAV4694", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Mild Cognitive Impairment", 
        "lastchanged_date": "May 16, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Christina.Chong@bannerhealth.com", 
                    "last_name": "Christina Chong", 
                    "phone": "632-832-8790"
                }, 
                "facility": {
                    "address": {
                        "city": "Sun City", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85351"
                    }, 
                    "name": "Banner Sun Health Research Institute"
                }, 
                "investigator": {
                    "last_name": "Marwan Sabbagh, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "luisp@galizresearch.com", 
                    "last_name": "Luis Pedraza", 
                    "phone": "305-805-0921"
                }, 
                "facility": {
                    "address": {
                        "city": "Hialeah", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33016"
                    }, 
                    "name": "Galiz Research"
                }, 
                "investigator": {
                    "last_name": "Jose Gamez, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33140"
                    }, 
                    "name": "Mt. Sinai Wien Center for Alzheimer's Disease"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "Lindsay_M_Pluff@rush.edu", 
                    "last_name": "Lindsay Pluff", 
                    "phone": "312-563-4111"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Raj Shah, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Elk Grove Village", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60007"
                    }, 
                    "name": "Alexian Brothers Neurosciences Institute"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "contact": {
                    "email": "blokaitis@siumed.edu", 
                    "last_name": "Barbara Lokaitis", 
                    "phone": "217-545-9737"
                }, 
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62702"
                    }, 
                    "name": "SIU School of Medicine"
                }, 
                "investigator": {
                    "last_name": "Thomas A Ala, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mpritchard1@partners.org", 
                    "last_name": "Melissa Pritchard", 
                    "phone": "617-855-2649"
                }, 
                "facility": {
                    "address": {
                        "city": "Belmont", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02478"
                    }, 
                    "name": "McLean Hospital"
                }, 
                "investigator": {
                    "last_name": "James M Ellison, M.D., MPH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hayley@thealzcenter.org", 
                    "last_name": "Hayley Brooks", 
                    "phone": "617-302-6388"
                }, 
                "facility": {
                    "address": {
                        "city": "Quincy", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02169"
                    }, 
                    "name": "Qunicy Medical Center, Alzheimer's Disease Center"
                }, 
                "investigator": {
                    "last_name": "Anil Nair, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "research@naaresearch.com", 
                    "last_name": "MaryEllen Torrisi", 
                    "phone": "518-426-0575"
                }, 
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "12208"
                    }, 
                    "name": "Neurological Associates of Albany"
                }, 
                "investigator": {
                    "last_name": "Richard Holub, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "csollars@montefiore.org", 
                    "last_name": "Mark Sollars", 
                    "phone": "718-405-8363"
                }, 
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10461"
                    }, 
                    "name": "Albert Einstein College of Medicine"
                }, 
                "investigator": {
                    "last_name": "Jessica Zwerling, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI)", 
        "overall_contact": {
            "email": "jshuping@navidea.com", 
            "last_name": "Joanna Shuping", 
            "phone": "614-793-7500", 
            "phone_ext": "162"
        }, 
        "overall_contact_backup": {
            "email": "chartings@navidea.com", 
            "last_name": "Carley Hartings", 
            "phone": "614-793-7500", 
            "phone_ext": "158"
        }, 
        "overall_official": {
            "affiliation": "Navidea Biopharmaceuticals Inc.", 
            "last_name": "Cornelia Reininger, MD, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Incidence of Mild Cognitive Impairment Progression to Alzheimer's Disease", 
            "measure": "Incidence of Mild Cognitive Impairment Progression to Alzheimer's Disease", 
            "safety_issue": "No", 
            "time_frame": "3 Years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01812213"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Incidence of [18F]NAV4694 PET Positive scans  at 18 months compared to baseline", 
                "measure": "Incidence of [18F]NAV4694 PET Positive scans at 18 months compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "description": "Incidence of [18F]NAV4694 PET Positive scans at 36 months compared to baseline", 
                "measure": "Incidence of [18F]NAV4694 PET Positive scans at 36 months compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }, 
            {
                "description": "Change in Neuro-cognitive Test Battery Scores at 6 months compared to baseline", 
                "measure": "Change in Neuro-cognitive Test Battery Scores at 6 months compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Change in Neuro-cognitive Test Battery Scores at 12 months compared to baseline", 
                "measure": "Change in Neuro-cognitive Test Battery Scores at 12 months compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Change in Neuro-cognitive Test Battery Scores at 18 months compared to baseline", 
                "measure": "Change in Neuro-cognitive Test Battery Scores at 18 months compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "description": "Change in Neuro-cognitive Test Battery Scores at 24 months compared to baseline", 
                "measure": "Change in Neuro-cognitive Test Battery Scores at 24 months compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "description": "Change in Neuro-cognitive Test Battery Scores at 30 months compared to baseline", 
                "measure": "Change in Neuro-cognitive Test Battery Scores at 30 months compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "30 months"
            }, 
            {
                "description": "Change in Neuro-cognitive Test Battery Scores at 36 months compared to baseline", 
                "measure": "Change in Neuro-cognitive Test Battery Scores at 36 months compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "36 months"
            }, 
            {
                "description": "Change in SUVR scores at 18 months compared to baseline", 
                "measure": "Change in SUVR scores at 18 months compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "36 months"
            }, 
            {
                "description": "Incidence of Adverse Events post baseline", 
                "measure": "Incidence of Adverse Events post baseline", 
                "safety_issue": "Yes", 
                "time_frame": "3 Years"
            }
        ], 
        "source": "Navidea Biopharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Navidea Biopharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}